A viral framework for how AI is collapsing the org chart is circulating in startup circles — and it maps directly onto where investors are placing their money.

As Cosmoprof Worldwide Bologna wraps its 57th edition this week, AI, biotech, and venture capital are converging on a sector that has long outpaced the attention it receives from institutional investors.

Michel Del Buono, CIO of Andreessen Horowitz’s a16z Perennial, explains why $50M-$1B+ portfolios fall into a structural no man’s land — and what founders must do before the next wave of mega-IPOs.

When every enterprise is already sold on AI, order-takers look like rock stars. The question investors should be asking: what happens when inbound dries up?

Leopold Aschenbrenner’s Situational Awareness fund is betting on power plants and data centers, not models. VCs are paying attention.

The productivity data on neurodivergent workers has been hiding in plain sight for a decade, and AI is making it obvious. Alex Karp just decided to act on it.

Apple Tree Partners says Chapter 11 protects life-saving research. Its primary backer says it is an unprecedented maneuver to avoid a governance trial in the Cayman Islands. A Delaware bankruptcy judge will soon decide which argument holds up.

The $183 billion software PE firm released LP meeting materials arguing that AI-fear-driven selling is indiscriminate, creating a historic acquisition window — while also conceding that some disruption is real.

Humanoid robots are attracting capital at a pace the underlying technology cannot yet justify. Between viral dance performances, stratospheric valuations, and foundation models that have never turned a production shift, a meaningful gap has opened betw…

The Sequoia co-steward argues that the rush to measure AI deployment obscures a more consequential question: whether AI is improving decision-making or accelerating mistakes.